EUCR
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
EUCR
Delisted
EUCR was delisted on the 26th of April, 2023.
39 hedge funds and large institutions have $64.6M invested in Eucrates Biomedical Acquisition Corp. Ordinary Shares in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
+5
Holders Change %
+14.71%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
7
Reduced
5
Closed
5
Calls
$15K
Puts
–
Net Calls
+$15K
Net Calls Change
-$4K
Top Buyers
1 |
DM
Deerfield Management
New York
|
+$9.76M |
2 |
D.E. Shaw & Co
New York
|
+$2.96M |
3 |
ECU
Eisler Capital (UK)
London,
United Kingdom
|
+$2.27M |
4 |
Bank of America
Charlotte,
North Carolina
|
+$1.39M |
5 |
CIM
Cowen Investment Management
New York
|
+$729K |
Top Sellers
1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$3.22M |
2 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$833K |
3 |
SC
Shay Capital
New York
|
-$663K |
4 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$313K |
5 |
BlackRock
New York
|
-$243K |